![John Niederhuber](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Niederhuber
Chairman at APTEVO THERAPEUTICS INC.
Net worth: 155 $ as of 31/05/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jeffrey Lamothe | M | 58 | 8 years | |
Marvin White | M | 61 | 14 years | |
SoYoung Kwon | F | 56 | 3 years | |
Daphne Taylor | F | 57 | 8 years | |
Fuad El Hibri | M | 66 |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | 7 years |
Barbara Lopez-Kunz | F | 66 | 8 years | |
Daniel Abdun-Nabi | M | 69 | 8 years | |
Richard Ellis | M | - |
Alpha Omega Alpha Honor Medical Society
![]() Alpha Omega Alpha Honor Medical Society Miscellaneous Commercial ServicesCommercial Services Alpha Omega Alpha Honor Medical Society is a national medical honor society founded in 1902. The non-profit company is based in Menlo Park, CA. The society's mission is to foster the development of the next generation of medical researchers by recognizing high educational achievement, honoring gifted teaching, encouraging the development of leaders in academia and the community, and supporting the improvement of care for all. | - |
Grady Grant | M | 68 | 8 years | |
Zsolt Pál Harsányi | M | 80 | 8 years | |
Stephen McLean | M | 66 |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | - |
Mark Gignac | M | - |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 5 years |
Robert Day | M | - |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 5 years |
Michael Perham | M | - |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 5 years |
Denise Toney | F | - |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 5 years |
John L. Newby | M | - |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 5 years |
Randi Balletta | F | - |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | - |
Ann W. Jackson | F | - |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | - |
Jeremy P. Goldberg | M | - |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | - |
Jeffrey I. Auerbach | M | - |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | - |
Alan Jones | M | - |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | - |
James Ramey | M | - |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 2 years |
Payam Pourtaheri | M | - |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 2 years |
Jeffrey Pompeo | M | - |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 6 years |
Nikki Hastings | F | - |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 2 years |
P. Vagelos | M | 94 |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | - |
William Winkenwerder | M | 69 |
C-Change
| - |
Kathryn Zoon | M | 75 |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | - |
Alex Euler | M | - |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 5 years |
Pearl Moore | F | - |
C-Change
| 20 years |
William J. Mayer | M | - |
C-Change
| - |
Kyp Sirinakis | F | - |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 6 years |
Reginald Seeto | M | 52 |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 8 years |
Alan Jones | M | - |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | - |
Garry P. Warren | M | - |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 2 years |
Harold E. Varmus | M | - |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | 8 years |
Cary Claiborne | M | 64 |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 2 years |
Scott Koenig | M | 71 |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | - |
James C. Powers | M | 71 |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 5 years |
Gerry Brunk | M | 55 |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 2 years |
Martin Rosenberg | M | 78 |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | - |
Ralph Snyderman | M | 84 |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | - |
Scott Lowman | M | - |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Harry Palmin | M | 54 |
Novelos Therapeutics, Inc.
![]() Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 15 years |
Anatolio Cruz | M | 65 | 3 years | |
Mitch A. Mondry | M | - |
University of Michigan
| 8 years |
George H. Vincent | M | - |
University of Michigan
| 7 years |
R. Elsey | M | 71 | 7 years | |
Jeffrey M. Gallagher | M | - |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | 7 years |
James Manuso | M | 75 |
Novelos Therapeutics, Inc.
![]() Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 7 years |
Jamey P. Weichert | M | 67 |
Novelos Therapeutics, Inc.
![]() Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI.
University of Michigan
| 7 years |
Joanne M. Protano | F | 55 |
Novelos Therapeutics, Inc.
![]() Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 8 years |
Jerome Hauer | M | 72 | 15 years | |
Shawnte Mitchell | F | 46 | - | |
John Patrick Genn | M | 67 |
Novelos Therapeutics, Inc.
![]() Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 3 years |
Nuno María Pestana de Almeida Alves | M | 66 |
University of Michigan
| 7 years |
Peter Menard | M | 70 |
University of Michigan
| 4 years |
Monica Rimai | F | - |
University of Michigan
| 7 years |
Bruce R. Maxim | M | 70 |
University of Michigan
| 5 years |
Hung Shih | M | 68 |
University of Michigan
| 5 years |
Paul F. DePond | M | 69 |
University of Michigan
| 5 years |
William R. Gillespie | M | - |
University of Michigan
| 4 years |
Jamal Abdulrazak Al-Mudaiheem | M | 66 |
University of Michigan
| 4 years |
Jennifer Siciliano | F | - |
Inova Health System Services
![]() Inova Health System Services Hospital/Nursing ManagementHealth Services Inova Health System provides health care services. It operates a network of hospitals, nursing homes, assisted living facilities, outpatient services and facilities, primary and specialty care physician practices, emergency and urgent care centers, home health care, mental health and blood donor services, wellness classes, and more. The company was founded in 1956 and is headquartered in Falls Church, VA. | 10 years |
Andrew Dallas | M | - |
University of Michigan
| 6 years |
Beverly J. Seay | F | - |
University of Michigan
| 6 years |
Karl R. Fink | M | - |
University of Michigan
| 7 years |
Elif McDonald | F | - | - | |
Yos Effendi Susanto | M | 73 |
University of Michigan
| 3 years |
Gerald I. Wilson | M | - |
University of Michigan
| 3 years |
Kevyn Duane Orr | M | 66 |
University of Michigan
| 8 years |
Lawrence Wieser | M | - |
University of Michigan
| 6 years |
Per A. Ramfjord | M | - |
University of Michigan
| 8 years |
Charan Behl | M | 72 |
University of Michigan
| 5 years |
Jim DePorre | M | - |
University of Michigan
| 8 years |
Haithem Karim Sarafa | M | - |
University of Michigan
| 5 years |
Scott Stromatt | M | 66 | - | |
Daniel Hamburger | M | 60 |
University of Michigan
| 5 years |
Michael A. Sosin | M | 64 |
University of Michigan
| 8 years |
George Joulwan | M | 84 | 10 years | |
Stephen Hill | M | 65 |
Novelos Therapeutics, Inc.
![]() Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 7 years |
David Russell Borger | M | - |
University of Michigan
| 3 years |
Mike Sayama | M | 69 |
University of Michigan
| 4 years |
Arthur Chadwick | M | 67 |
University of Michigan
| 6 years |
Alan G. Merten | M | 83 |
University of Michigan
Inova Health System Services
![]() Inova Health System Services Hospital/Nursing ManagementHealth Services Inova Health System provides health care services. It operates a network of hospitals, nursing homes, assisted living facilities, outpatient services and facilities, primary and specialty care physician practices, emergency and urgent care centers, home health care, mental health and blood donor services, wellness classes, and more. The company was founded in 1956 and is headquartered in Falls Church, VA. | 7 years |
Anmar Karim Sarafa | M | - |
University of Michigan
| 4 years |
Elliot Noma | M | - |
University of Michigan
| 4 years |
Michael J. Barton | M | - |
University of Michigan
| 6 years |
Mary L. Campbell | F | - |
University of Michigan
| 2 years |
Rama Krishna | M | 60 |
University of Michigan
| 3 years |
Frederick Chavalit Tsao | M | 67 |
University of Michigan
| 6 years |
David E. Goldberg | M | - |
University of Michigan
| 5 years |
William Banyai | M | 69 |
University of Michigan
| 6 years |
Sudhakar Kesavan | M | 69 |
Inova Health System Services
![]() Inova Health System Services Hospital/Nursing ManagementHealth Services Inova Health System provides health care services. It operates a network of hospitals, nursing homes, assisted living facilities, outpatient services and facilities, primary and specialty care physician practices, emergency and urgent care centers, home health care, mental health and blood donor services, wellness classes, and more. The company was founded in 1956 and is headquartered in Falls Church, VA. | - |
Prokopios Tsirigakis | M | 69 |
University of Michigan
| 5 years |
Eric R. Ridenour | M | 65 |
University of Michigan
| 7 years |
John Sloss | M | - |
University of Michigan
| 7 years |
Howard M. Schneider | M | 80 |
Novelos Therapeutics, Inc.
![]() Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 9 years |
Barbara L. Silkworth | F | - |
University of Michigan
| 5 years |
Alex Horvitz | M | - |
University of Michigan
| 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Niederhuber
- Personal Network